ColinCSchott-PethelazAM. Mammographic density as a risk factor: to go out of a 30-year fog. Acta Radiol2017; 58.
2.
WinkelRRvon Euler-ChelpinMNielsenM. Interobserver agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: Impact on relative risk of breast cancer. BMC Cancer2015; 15: 274–274.
3.
ColinCSchottAMValettePJ. Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening. Eur Radiol2014; 24: 2412–2416.
4.
FreerPE. Mammographic breast density: Impact on breast cancer risk and implications for screening. Radiographics2015; 35: 302–315.
5.
RiedlCCLuftNBernhartC. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and question the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol2015; 33: 1128–1135.
6.
RaffertyEADurandMAConantEF. Breast cancer screening using tomosynthesis and digital mammography in dense and nondense breasts. JAMA2016; 315: 1784–1786.
7.
TagliaficoASCalabreseMMariscottiG. Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial. J Clin Oncol2016; 34: 1882–1888.
8.
Kuhl CK, Strobel K, Bieling H, et al. Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology 2017. DOI:10.1148/radiol.2016161444.
9.
HaasJSKaplanCP. The divide between breast density notification laws and evidence-based guidelines for breast cancer screening. JAMA Intern Med2015; 175: 1439–1440.
10.
SardanelliFFallenbergEMClauserP. Mammography: an update of the EUSOBI recommendations on information for women. Insights Imaging2017; 8: 11–18.
